Urticaria Tracking with CRUSE: A Game-Changer for Patients & Research

Urticaria Tracking with CRUSE: A Game-Changer for Patients & Research

In this episode, Prof. Dr. Torsten Zuberbier (GA²LEN) welcomes Dr. Sophia Neisinger to discuss CRUSE, a digital health tool for chronic spontaneous urticaria (CSU). CRUSE is a free, globally available self-evaluation app that helps patients track their symptoms and provides valuable research data to improve urticaria care.


They discuss:

📊 How CRUSE helps patients track their CSU symptoms daily.

🔬 How anonymized CRUSE data is shaping global urticaria research.

📢 The importance of continuous data input—even on good days.

💊 Treatment disparities worldwide & the fight against long-term corticosteroid use.

📡 Upcoming developments, including smartwatch & wearable integration.

Join us as we explore how CRUSE is making a difference for patients, physicians, and researchers worldwide!

Key Learnings from the Episode:

CRUSE is a free, validated self-evaluation app for CSU patients, helping track their disease and treatment effectiveness.

Daily symptom tracking is crucial, even when patients feel well, to improve research insights.

CRUSE data reveals treatment disparities worldwide, with some countries lacking access to second-line treatments.

Systemic corticosteroids are still overused, despite their severe side effects, highlighting the need for better awareness and alternative treatments.

CRUSE allows patients to share their symptom data with their physicians, improving personalized treatment decisions.

The app is continuously evolving, with new features like improved reports and future integration with smartwatches and wearables.

CRUSE is expanding globally, with North Macedonia being the next country to adopt the platform.

Physicians and researchers can use CRUSE for studies, making it a valuable tool for small-scale trials and real-world data collection.


Chapters

00:00 Introduction to CRUISE and Its Purpose

03:18 Data Collection and Patient Engagement

05:47 Global Insights from CRUISE Data

08:52 Future Developments and Enhancements

11:35 Awareness and Advocacy for Urticaria


Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.


Feedback form:

ATU: ⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(121)

AI and the Future of Urticaria

AI and the Future of Urticaria

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intellig...

16 Jun 16min

Urticaria Triggers: Infection Insights

Urticaria Triggers: Infection Insights

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chroni...

19 Mai 16min

A New Era in Urticaria Treatment

A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released inte...

23 Apr 19min

Managing Urticaria in Resource-Limited Settings

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Mar 17min

Drug Survival of Omalizumab

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Feb 17min

Visualizing Urticaria Worldwide

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Jan 19min

A New Era for Urticaria Treatment

A New Era for Urticaria Treatment

In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the...

18 Des 20255min

Measuring What Matters: PROMs in Urticaria Care

Measuring What Matters: PROMs in Urticaria Care

In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer ...

2 Des 202519min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
rekommandert
forskningno
sinnsyn
villmarksliv
smart-forklart
dekodet-2
tomprat-med-gunnar-tjomlid
fjellsportpodden
rss-nysgjerrige-norge
noen-har-snakket-sammen
rss-inn-til-kjernen-med-sunniva-rose
rss-overskuddsliv
rss-paradigmepodden
vett-og-vitenskap-med-gaute-einevoll
rss-rekommandert
rss-bondevennen